The obtained radiomic score identified tumor subtypes (luminal vs. non-luminal; HER+/− and triple-negative vs. non-triple-negative) with AUC 0.856 for luminal versus non-luminal, 0.818 for HER2+, and 0.888 for triple-negative versus non-triple-negative. The gene discussed is ERBB2; the disease is neoplasm.